Trial: 202005122

First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1046 in subjects with malignant solid tumors

Phase

I/II

Principal Investigator

Ward, Jeffrey

Disease Site

Breast; Cervix; Corpus Uteri; Ill-Defined Sites; Lip, Oral Cavity and Pharynx; Lung; Lung Cancer – Non-small Cell; Urinary Bladder

Learn more about this study at: clinicaltrials.gov